Finding 1159856 (2024-001)

Material Weakness Repeat Finding
Requirement
C
Questioned Costs
-
Year
2024
Accepted
2025-10-03

AI Summary

  • Core Issue: Lack of documented review and approval for reimbursement requests, raising concerns about compliance with federal requirements.
  • Impacted Requirements: 2 CFR 200.303 mandates effective internal controls to ensure expenditures are incurred before reimbursement requests are submitted.
  • Recommended Follow-Up: Implement a process for reviewers to sign off on reimbursement requests to confirm that proper review has occurred.

Finding Text

Finding No. 2024-001 – Cash Management | Identification of the Program: | Program Name: Research and Development Cluster: Basic Scientific Research, Department of Defense Awarding Office, 12.431; NSF Technology, Innovation and Partnerships, National Science Foundation, 47.084 | Criteria or Specific Requirements (Including Statutory, Regulatory, or Other Citations): 2 CFR 200.303 requires that a non-Federal entity must “(a) establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States and the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).” According to page 3-C-5 of the 2024 OMB Compliance Supplement, expenses must be incurred before submitting a reimbursement request (2 CFR § 200.305(b)(3)). | Condition: During our testing of 2024 reimbursement requests (totaling $536,272), we noted that there was no evidence of review and approval of the requests to indicate whether the reviewer determined that expenditures submitted for reimbursement had been incurred prior to the request for reimbursement. Management has indicated this review does, in fact, take place, however, there is no evidence (i.e., sign off) on the request to indicate that the review had occurred. | Section III— Federal Award Findings and Questioned Costs (continued) | Cause: Internal controls over the review and approval of the reimbursement requests were not effective. | Effect or Potential Effect: This could result in reimbursement for expenditures that have not been incurred and paid prior to reimbursement being requested. | Questioned Costs: None. | Context: As the sample size is small, we selected 10 cash disbursements for testing. There was no evidence of approval for all 10 reimbursement requests. | Identification as a Repeat Finding: N/A – This is a first year Uniform Guidance audit. | Recommendation: Management should strengthen its internal controls over cash management related to reimbursement requests by having the reviewer sign off on the reimbursement request to support that the review had occurred. | View of Responsible Officials: Management concurs with the findings and has developed a corrective action plan to address this finding.

Corrective Action Plan

For all grant reimbursement requests we will now have an addtional person to review and sign off on the reimbursement request.

Categories

Cash Management Matching / Level of Effort / Earmarking

Other Findings in this Audit

  • 1159854 2024-001
    Material Weakness Repeat
  • 1159855 2024-002
    Material Weakness Repeat
  • 1159857 2024-002
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
12.431 Flux Failure Modes Characterization and Mitigations in High Density Superconductor $1.05M
47.084 Central Florida Semiconductor Innovation Engine $340,737